Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Ciba Vision launches Ophthalin in U.K.

April 1, 1997

Two dose regimens of latanoprost compared in glaucoma patients

March 25, 1997

Alphagan receives first European approval

March 25, 1997

Alcon prepares carbonic anhydrase inhibitors

March 13, 1997

Positive phase I results for new formulation of lexipafant

March 12, 1997

Gene linked to juvenile macular degeneration cloned

March 7, 1997

Nonsurgical treatment for vitreous hemorrhage enters clinic in the U.S.

March 6, 1997

Medarex acquires Houston Biotechnology

March 5, 1997

Dorzolamide and timolol alone and in combination for glaucoma

March 4, 1997

AEterna codevelopment agreement for AE-941

Feb. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...